XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 9,675 $ 8,096
Short-term investments 453 0
Accounts receivable (net of allowance for doubtful accounts of $82 in 2022 and $62 in 2021) 9,643 9,230
Inventories (excludes inventories of $2,764 in 2022 and $2,194 in 2021 classified in Other assets - see Note 7) 5,535 5,953
Other current assets 6,810 6,987
Total current assets 32,116 30,266
Investments 238 370
Property, Plant and Equipment, at cost, net of accumulated depreciation of $17,798 in 2022 and $18,192 in 2021 20,059 19,279
Goodwill 21,213 21,264
Other Intangibles, Net 22,497 22,933
Other Assets 10,972 11,582
Total Assets 107,095 105,694
Current Liabilities    
Loans payable and current portion of long-term debt 2,979 2,412
Trade accounts payable 3,482 4,609
Accrued and other current liabilities 13,501 13,859
Income taxes payable 1,438 1,224
Dividends payable 1,768 1,768
Total current liabilities 23,168 23,872
Long-Term Debt 28,684 30,690
Deferred Income Taxes 2,974 3,441
Other Noncurrent Liabilities 8,951 9,434
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2022 and 2021 1,788 1,788
Other paid-in capital 44,115 44,238
Retained earnings 58,437 53,696
Accumulated other comprehensive loss (4,327) (4,429)
Stockholders' equity before deduction for treasury stock 100,013 95,293
Less treasury stock, at cost: 1,043,894,068 shares in 2022 and 1,049,499,023 shares in 2021 56,770 57,109
Total Merck & Co., Inc. stockholders’ equity 43,243 38,184
Noncontrolling Interests 75 73
Total equity 43,318 38,257
Liabilities and Equity $ 107,095 $ 105,694